Benzodiazepine Prescribing in Utah
Medicare Part D, 2013–2024.
Benzodiazepine prescribing in Utah fell 5.8% between 2013 and 2024 — a slower fall than the country as a whole. In 2024 the state recorded 213,718 Medicare Part D benzodiazepine claims across 46,730 patients, an average of 4.57 fills per patient per year, which ranks 29 of 51 states. Alprazolam accounts for 31.4% of it.
Utah over twelve years
Which benzodiazepines Utah prescribes
| Drug | Claims 2024 | Share |
|---|---|---|
| Alprazolam | 67,105 | 31.4% |
| Clonazepam | 58,479 | 27.4% |
| Lorazepam | 46,052 | 21.5% |
| Diazepam | 24,277 | 11.4% |
| Temazepam | 14,893 | 7% |
Psychiatric prescribers in Utah
88 psychiatric prescribers in Utah appear in the 2024 Medicare Part D data with benzodiazepine claims. 5 of them recorded at least a 50% fall in benzodiazepine claims since 2019. Sorted by change, largest reduction first.
This is a record, not a recommendation. A fall in Medicare benzodiazepine claims has many possible explanations — a changing patient panel, retirement, a shift to another payer, or simply dropping below the threshold CMS publishes. It does not establish that a prescriber supports tapering, and a low number does not mean they will take you as a patient. Use it as one input, then ask the five vetting questions.
| Prescriber | City | 2019 | 2024 | Change |
|---|---|---|---|---|
| Eric BarkerPsychiatry | Logan | 177 | 22 | -87.6% |
| Paula GibbsPsychiatry | Salt Lake City | 96 | 20 | -79.2% |
| Michael RoundyPsychiatry | Bountiful | 500 | 135 | -73% |
| Steven SugdenPsychiatry | Salt Lake City | 56 | 16 | -71.4% |
| Monica PolkPsychiatry | Draper | 35 | 12 | -65.7% |
| Melissa Lopez-LarsonNeuropsychiatry | Salt Lake City | 45 | 27 | -40% |
| Michael KligmanPsychiatry & Neurology | Salt Lake City | 126 | 80 | -36.5% |
| Paolo MorettiNeuropsychiatry | Salt Lake City | 67 | 45 | -32.8% |
| Joseph YauPsychiatry | Taylorsville | 452 | 311 | -31.2% |
| Bryan MauldenPsychiatry | Midvale | 541 | 379 | -29.9% |
| Richard DavidsonPsychiatry | Ogden | 35 | 25 | -28.6% |
| Marc DavisPsychiatry | Salt Lake City | 279 | 206 | -26.2% |
| Tim McgaughyPsychiatry | Provo | 801 | 596 | -25.6% |
| Thomas ReidPsychiatry | Tooele | 432 | 348 | -19.4% |
| George ZinkhanNeuropsychiatry | Salt Lake City | 193 | 157 | -18.7% |
| Lisa FraleighPsychiatry & Neurology | Logan | 60 | 52 | -13.3% |
| Martin FreimerGeriatric Psychiatry | Salt Lake City | 147 | 132 | -10.2% |
| Nathan CurrierPsychiatry | Salt Lake City | 828 | 751 | -9.3% |
| Steven TeynorPsychiatry | Holladay | 301 | 275 | -8.6% |
| Nancy PantzirisPsychiatry | Bountiful | 193 | 178 | -7.8% |
| Glen JohnsonPsychiatry | West Valley City | 923 | 897 | -2.8% |
| Mark FootePsychiatry | Salt Lake City | 478 | 466 | -2.5% |
| Robert WallacePsychiatry | Salt Lake City | 381 | 377 | -1% |
| Joshua MitchellPsychiatry | Salt Lake City | 118 | 118 | 0% |
| Michaela MohrPsychiatry & Neurology | Salt Lake City | 134 | 144 | +7.5% |
| Matthew MoenchPsychiatry | Salt Lake City | 165 | 178 | +7.9% |
| Ludmil ManovPsychiatry | American Fork | 88 | 101 | +14.8% |
| Trent HolmbergNeuropsychiatry | Draper | 117 | 137 | +17.1% |
| Darrell RobergePsychiatry | Salt Lake City | 160 | 198 | +23.8% |
| Dennis SmithPsychiatry | Ogden | 606 | 752 | +24.1% |
| Eric CatenPsychiatry | Taylorsville | 416 | 518 | +24.5% |
| Julana SchenkPsychiatry | Layton | 363 | 452 | +24.5% |
| Robert StrongNeuropsychiatry | Salt Lake City | 200 | 249 | +24.5% |
| Paul StevensNeuropsychiatry | Salt Lake City | 395 | 493 | +24.8% |
| David PaulsonPsychiatry | Orem | 189 | 254 | +34.4% |
| Nancy BivensPsychiatry | Salt Lake City | 53 | 72 | +35.8% |
| Austin ImusPsychiatry | Bountiful | 20 | 28 | +40% |
| Mark NeumanPsychiatry | Salt Lake City | 346 | 489 | +41.3% |
| Samuel WeberPsychiatry | Logan | 177 | 270 | +52.5% |
| Ryan WilliamsPsychiatry | Cedar City | 47 | 73 | +55.3% |
| Imran RajaPsychiatry | Cottonwood Heights | 393 | 613 | +56% |
| Gregory EllisPsychiatry & Neurology | Cottonwood Heights | 113 | 178 | +57.5% |
| Carmela JavellanaPsychiatry | Bountiful | 90 | 144 | +60% |
| Michael HarrisPsychiatry & Neurology | Provo | 25 | 40 | +60% |
| David SchaeferPsychiatry | Saint George | 104 | 174 | +67.3% |
| Julie WiesePsychiatry | Layton | 366 | 634 | +73.2% |
| Michael LowryPsychiatry | Salt Lake City | 90 | 179 | +98.9% |
| Shannon GullettPsychiatry | Murray | 177 | 362 | +104.5% |
| Rachel MoranoPsychiatry | Ogden | 26 | 59 | +126.9% |
| Michael KalmPsychiatry & Neurology | Salt Lake City | 13 | 34 | +161.5% |
| Duane BanksPsychiatry | Murray | 201 | 538 | +167.7% |
| Angelique GoodhuePsychiatry | Midvale | 70 | 195 | +178.6% |
| Anne LinPsychiatry | Salt Lake City | 68 | 211 | +210.3% |
| Jeremy ThuesonPsychiatry | Salt Lake City | 29 | 147 | +406.9% |
| Keerthi VejerlaPsychiatry | Salt Lake City | 13 | 93 | +615.4% |
| Christopher VinegraPsychiatry | Salt Lake City | 20 | 203 | +915% |
| Isabella TcaciucPsychiatry | Slc | — | 247 | — |
| Benjamin Van LeeuwenPsychiatry | Layton | — | 181 | — |
| Laura RomerPsychiatry | St George | — | 149 | — |
| Spencer HansenPsychiatry | Slc | — | 138 | — |
| Michael PopePsychiatry | Salt Lake City | — | 129 | — |
| Daniel VinePsychiatry & Neurology | St George | — | 110 | — |
| Robert ReynoldsPsychiatry | Murray | — | 77 | — |
| Jeremy LarsonPsychiatry | St George | — | 64 | — |
| Sheena RayPsychiatry & Neurology | Draper | — | 59 | — |
| Jordan KoncinskyPsychiatry | Salt Lake City | — | 56 | — |
| Phillip GunnellPsychiatry | Logan | — | 49 | — |
| Julian ThornePsychiatry | Salt Lake City | — | 45 | — |
| Awais RiazNeuropsychiatry | Salt Lake City | — | 36 | — |
| Hans WatsonPsychiatry | South Jordan | — | 31 | — |
| Scott SalomonePsychiatry | Murray | — | 26 | — |
| Kylee JenkinsPsychiatry & Neurology | Salt Lake City | — | 26 | — |
| Brigham FossonAddiction Medicine | Provo | — | 25 | — |
| Jaremy HillPsychiatry | Bountiful | — | 23 | — |
| Brent GriffinPsychiatry | Provo | — | 19 | — |
| Tyler DurnsPsychiatry | Salt Lake City | — | 19 | — |
| Ioanna DoukaPsychiatry & Neurology | Salt Lake City | — | 17 | — |
| Anthony VitaPsychiatry | Layton | — | 16 | — |
| Spencer SteadmanNeuropsychiatry | Salt Lake City | — | 15 | — |
| Sean UdellPsychiatry | Park City | — | 15 | — |
| Mary GeezePsychiatry & Neurology | Salt Lake City | — | 14 | — |
| Samia NawazPsychiatry & Neurology | Salt Lake City | — | 14 | — |
| Thomas RaynerPsychiatry | Provo | — | 14 | — |
| Jordan PeacockPsychiatry & Neurology | Salt Lake City | — | 12 | — |
| Barry KingPsychiatry & Neurology | Orem | — | 12 | — |
| Nelson DouglassNeuropsychiatry | Salt Lake City | — | 12 | — |
| Kristen DurbinPsychiatry | Salt Lake City | — | 11 | — |
| Aaron SandersPsychiatry | Provo | — | 11 | — |
Figures are reproduced from the CMS public use files without alteration. Clinicians who believe a row misstates their record can write to support@taperoffbenzos.com and we will check it against the source file and correct or remove it.
Finding a prescriber in Utah
This data describes prescribing patterns; it does not tell you who will support a slow taper. For that, our guide to finding a benzo-wise prescriber compares every free provider directory that exists and lists the five questions that predict how a taper will go. If you already have a prescriber, the taper calculator generates a schedule to review with them.
Frequently asked questions
Is benzodiazepine prescribing rising or falling in Utah?
It fell 5.8% between 2013 and 2024 in Medicare Part D — a slower fall than the country as a whole, where prescribing fell 12.9%. In 2024, Utah recorded 213,718 benzodiazepine claims across 46,730 patients.
How does Utah compare to other states?
Utah ranks 29 of 51 for prescribing intensity, at 4.57 benzodiazepine fills per patient per year, and 37 of 51 for the size of its decline since 2013 (1 being the steepest fall).
Which benzodiazepine is prescribed most in Utah?
Alprazolam, at 67,105 claims — 31.4% of the state's benzodiazepine prescribing in 2024. Next are Clonazepam (27.4%) and Lorazepam (21.5%).
Source
CMS Medicare Part D Prescribers public use files, data years 2013–2024 (US Government work, public domain). Medicare Part D only — it excludes commercial insurance and cash-pay, skews toward patients 65 and over, and suppresses cells of 10 or fewer claims. Full methodology and limitations are on the national page.